Ligand-Gated Ion Channel Database

What is Lumpy Skin Disease Virus (LSDV)?

Lumpy Skin Disease Virus (LSDV) is a Capripoxvirus (family Poxviridae) that primarily infects bovines (cattle, water buffalo). It is closely related to sheeppox virus (SPPV) and goatpox virus (GTPV). Authoritative overviews and training materials are available from USDA APHIS and Iowa State University’s CFSPH (USDA APHIS FAD PReP SOP, CFSPH factsheet, updated Mar 2025, CFSPH disease info hub). For broad reviews of capripoxviruses and LSDV emergence and molecular pathogenesis, see NIH/NCBI-hosted resources (systematic review of transmission, global burden review, emergence review, molecular pathogenesis, capripox review).

Taxonomic references for LSDV and related capripoxviruses are maintained by NCBI (LSDV NI-2490 taxonomy, sheeppox taxonomy).

Anti-LSDV Antibodies and Antigen Selection (for RUO applications)

When designing or choosing anti-LSDV antibodies (monoclonal or polyclonal, RUO), typical antigen candidates include abundant and relatively conserved structural proteins (e.g., P32 homologs) and immunodominant membrane/virion proteins used in historic and contemporary assays. Selection should consider:

• Conservation within Capripoxvirus (minimize cross-reactivity vs SPPV/GTPV if specificity is desired) using reference sequences from NCBI (taxon page above).

• Epitope exposure in FFPE tissues vs fresh tissue for IHC; retrieval conditions may be required (alkaline HIER buffers often perform well for poxviral proteins in FFPE—optimize empirically).

• DIVA strategy in research (distinguishing infected vs vaccinated animals at the marker level in experimental settings is discussed in NIH-hosted capripox literature: capripox immunology/vaccines).

Because capripoxviruses are serologically very similar, molecular targets are typically preferred for typing; this cross-reactivity context is emphasized in PubMed reviews (B22R marker/phylogeny, GPCR marker use).

Sample Types and Pre-Analytical Considerations

For LSDV research workflows (RUO), commonly studied samples include skin nodules/scabs, whole blood (EDTA) during viremia, nasal/oral swabs, and occasionally lymph node or internal tissues (post-mortem). Stability in scabs is frequently noted in veterinary training materials (CFSPH slide deck). Field-ready extraction and transport protocols for capripox DNA have been explored in NIH-hosted studies (field-ready detection).

Molecular Targets & Assay Design (qPCR, HRM, Sequencing)

High-confidence molecular targets repeatedly used in the literature for LSDV/capripox detection, differentiation, and phylogeny include:

• GPCR gene (G-protein-coupled chemokine receptor homolog): frequently used for genotyping and phylogenetic analysis (PubMed GPCR paper; UMN-affiliated studies on GPCR phylogeny in outbreaks: UMN study 2017–2018).

• RPO30 (DNA-dependent RNA polymerase subunit, often used alongside GPCR) discussed in multiple capripox genomics reviews (capripox review on NIH).

• B22R-like homologs (orthopox reference; capripox phylogeny marker in some studies) (PubMed B22R marker).

• P32 (a major structural protein) used in serological/antigen design contexts (capripox immunology/vaccines review).

For quantitative PCR (qPCR), validated primers/probes are compiled in regulatory technical chapters (see USDA APHIS notes and annexes: APHIS chapter excerpt, annex version). Whole-genome differentiation and DIVA-like comparisons leverage short-read + long-read strategies (e.g., Illumina + Oxford Nanopore) (nanopore/Illumina for capripox; also PubMed outbreak sequencing notes: experimental work).

Research Serology (RUO) and Cross-Reactivity Context

Because the three capripoxviruses share high homology and are serologically indistinguishable in many classic assays, RUO ELISA-style formats targeting LSDV may detect SPPV/GTPV antibodies as well (unless specifically engineered using unique epitopes). This is emphasized in the NIH/NCBI literature and APHIS technical chapters (capripox review, APHIS chapter).

Biosafety and Laboratory Handling (Research Context)

General laboratory handling recommendations for capripoxviruses emphasize appropriate PPE, biological containment commensurate with local regulations, and careful handling of skin scabs which may harbor high DNA loads for extended periods (CFSPH training slide note on scab survival). For technical emergency preparedness and response, USDA APHIS FAD PReP documents are a key reference (FAD PReP SOP).

Vector Biology, Transmission, and Environmental Context

Multiple vectors (biting flies, mosquitoes, ticks) and mechanical transmission routes have been implicated for LSDV spread. Comprehensive syntheses hosted on NIH and CFSPH discuss seasonality, vector density, and animal movement as risk amplifiers (mode-of-transmission review, global burden/timelines, CFSPH factsheet).

Risk modeling for geographical spread is also covered by U.S. universities; see NC State news on LSDV risk mapping (NCSU research brief) and UMN-affiliated spatio-temporal studies (UMN spatial/temporal analysis).

For wildlife interface issues (e.g., spillover risks to sympatric species and conservation programs), Cornell wildlife health documents provide context for multi-host landscapes (Cornell wildlife report mentioning LSD, Cornell conservation vaccination briefing with LSD case reference).

Typical Research Workflow (End-to-End, RUO)

A. Sampling & storage
Collect skin nodules/scabs, whole blood (EDTA), or swabs. Keep cold; follow local biosafety handling. See CFSPH procedural overviews and APHIS preparedness docs (CFSPH factsheet, USDA APHIS SOP).

B. Nucleic acid extraction
Use validated DNA extraction kits appropriate for scab/tissue matrices. For low-resource contexts, see field-ready extraction/detection protocols for capripox DNA (field-ready detection).

C. qPCR screening
Design assays targeting GPCR and/or RPO30 with hydrolysis probes; include internal amplification controls. Reference APHIS technical chapters for primer/probe examples and validation notes (APHIS chapter, annex).

D. Genotyping / HRM / Sanger
Confirm positives by amplicon sequencing (e.g., GPCR locus) to distinguish LSDV clusters and compare to regional sequences. See UMN-affiliated molecular work (UMN GPCR study).

E. Whole-genome sequencing (Illumina + Nanopore)
Library prep with hybrid short-/long-read improves contiguity and resolves repeats; applicable approaches for capripox are detailed in NIH-hosted reports (nanopore/Illumina differentiation).

F. Serology (RUO)
Use ELISA formats built on conserved but discriminating epitopes; interpret cautiously because capripox serology is cross-reactive without DIVA design (capripox immunology review, CFSPH factsheet).

G. Archiving & data sharing
Deposit consensus sequences in GenBank/NCBI with proper metadata to strengthen comparative phylogeography (NCBI taxonomy landing as reference).

Interpreting Anti-LSDV Signals in the Lab (RUO)

• IHC/IF on FFPE: Try alkaline HIER buffers (optimize pH/time); select membrane/virion proteins for robust staining; include no-primary and known-positive controls.

• qPCR Ct values: Use standard curves and inhibition controls; repeat extract if Ct values are borderline.

• Sequencing confirmation: Use coverage depth and variant calling QC thresholds; cross-check with reference LSDV genomes.

• Serology: Expect cross-reactivity across capripox; interpret with molecular results and sampling timeline.

• Quality management: Follow checklists distilled in USDA APHIS technical documents and CFSPH training materials (APHIS SOP, CFSPH factsheet).

Spatial Risk, Ecology, and Research Trends

Recent syntheses highlight climate, vector seasonality, animal movement, and trade networks as key drivers of spread (global burden review, NIH; emergence review, NIH). Academic groups have modeled risk landscapes and spatiotemporal dynamics (NCSU modeling brief; UMN spatial analysis). Conservation-oriented research also considers wildlife–livestock interfaces (Cornell wildlife reports, Cornell conservation vaccination document).

SEO-Focused Meta Pack (ready to paste)

Suggested H1: Anti-Lumpy Skin Disease Virus (LSDV) for Research: Molecular Targets, Assay Design, and Laboratory Workflows
Meta title (≤60 chars): Anti-Lumpy Skin Disease Virus (LSDV) | Capripox Research
Meta description (≤160 chars): Technical guide to anti-LSDV research: markers (GPCR/RPO30), qPCR, sequencing, IHC antigens, RUO serology, and biosafety with .edu/.gov references.
Slug: /anti-lumpy-skin-disease-virus-lsdv-research-guide
Alt text template: “Anti-Lumpy Skin Disease Virus (LSDV) antibody detecting P32 protein in FFPE bovine skin nodule (HIER, alkaline pH)”

Internal linking ideas (for your blogs):

• “Capripox qPCR primer design guide”

• “Choosing alkaline HIER buffers for FFPE poxviral IHC”

• “RUO ELISA development: controlling cross-reactivity in capripox”